Review
Published on 13 Apr 2023
Ecological niches for colorectal cancer stem cell survival and thrival
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1135364
- 2,569 views
- 1 citation
Type at least 3 characters
1,009 articles
Articles
Case Report
Published on 06 Apr 2023
Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1151178
- 3,130 views
- 6 citations
Case Report
Published on 29 Mar 2023
Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1104910
- 1,649 views
Review
Published on 28 Mar 2023
Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1063051
- 3,653 views
- 4 citations
Editorial
Published on 28 Mar 2023
Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1180650
- 1,027 views
- 1 citation
Original Research
Published on 22 Mar 2023
Clinical efficacy of laparoscopic radical hepatectomy and laparotomy for hepatocellular carcinoma and factors of postoperative recurrence
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1116984
- 1,219 views
- 1 citation
Editorial
Published on 20 Mar 2023
Editorial: Emerging strategies for cancer therapy targeting ferroptosis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1181134
- 1,330 views
Review
Published on 17 Mar 2023
Exosomes and osteosarcoma drug resistance
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1133726
- 2,567 views
- 8 citations
Original Research
Published on 16 Mar 2023
Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1089234
- 1,658 views
Original Research
Published on 10 Mar 2023
Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1077640
- 2,738 views
- 2 citations
Original Research
Published on 10 Mar 2023
Ginseng-based carbon dots inhibit the growth of squamous cancer cells by increasing ferroptosis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1097692
- 3,450 views
- 5 citations
Original Research
Published on 08 Mar 2023
Exploring the components and mechanism of Solanum nigrum L. for colon cancer treatment based on network pharmacology and molecular docking
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1111799
- 3,967 views
- 8 citations
Review
Published on 08 Mar 2023
Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1038710
- 3,060 views
- 4 citations
Original Research
Published on 07 Mar 2023
Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1128785
- 1,962 views
- 2 citations
Editorial
Published on 07 Mar 2023
Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs, volume II
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1153714
- 1,414 views
- 4 citations
Editorial
Published on 06 Mar 2023
Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2023.1163144
- 1,044 views